HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
about
Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisPeritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyCurrent treatment options for colon cancer peritoneal carcinomatosis.Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendixRepeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience.Surgical treatment of peritoneal carcinomatosis: current treatment modalities.Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?Treatment of peritoneal metastases from small bowel adenocarcinoma.Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach.A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience.Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.
P2860
Q28077394-4D433677-1FF1-4987-8145-3586474110E1Q31031044-A5E2D951-20D0-4937-9D98-D21A0C1C604AQ34207816-F6E6F1BC-5516-4410-B703-E3334222F964Q34993227-D0D1868A-07B9-40DD-95B0-AA048EC3F188Q38155428-D58EF375-D07A-4E2C-A3D7-BC87394F6D8AQ38163913-32A4359B-1C5E-4CED-A272-714FE1984822Q38728196-8D480204-C921-47F1-B115-D4B6E7DD34B9Q38787018-26A58A04-9CF7-42BA-994F-9715C9AA25D8Q39310531-9053EAF7-3103-4BF4-B202-84BA19E5BCFDQ41547533-E3741C39-227E-46E6-BBF6-5AC4480DBAC2Q47133971-0A4B032E-58A1-4B57-A46F-639B7CBDD65CQ47151877-43579AF8-FD99-4077-AF7B-03128A768CBCQ47821560-4A33F61E-9DB0-4633-B569-0504C2CA2100Q50213512-CFDB8C2A-4D46-4284-9F6D-663ACDEF7DADQ52866005-566EFC7D-28E6-4E86-B7BA-412D923BA1D1
P2860
HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@en
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@nl
type
label
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@en
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@nl
prefLabel
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@en
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@nl
P2093
P2860
P356
P1476
HIPEC + EPIC versus HIPEC-alon ...... ery for peritoneal malignancy.
@en
P2093
Lloyd A Mack
Walley J Temple
Wesley P Francis
Yarrow J McConnell
P2860
P304
P356
10.1002/JSO.23276
P577
2012-11-05T00:00:00Z